<DOC>
	<DOCNO>NCT01717209</DOCNO>
	<brief_summary>Research study evaluate individual combined effect inhale medication , nitric oxide prostacyclin , function right heart surgery either heart transplant leave ventricular assist device ( LVAD ) placement . The investigator hope learn two medication , give together surgery , improve right heart function lower blood vessel pressure lung . The investigator hope learn combine effect two medication well either medication use alone . Participants select possible participant study right heart problem common surgery heart transplant LVAD placement . In addition , inhaled medication , nitric oxide , always give two type surgery Stanford help improve right heart function .</brief_summary>
	<brief_title>Inhaled Nitric Oxide Inhaled Prostacyclin After Cardiac Surgery Heart Transplant LVAD Placement</brief_title>
	<detailed_description>The study begin participant arrives CTICU heart surgery either heart transplant LVAD placement . As standard care type surgery , participant arrive CTICU breathe tube already place , receive iNO , connect breathing machine . The participant receiving relax medication intravenous line provide cardiac anesthesiologist CTICU physician . The participant unaware study period participant sedate . Data collect monitor screen connect participant'sarterial venous line , place , LVAD monitor . These data : Central venous pressure ( CVP ) Mean arterial pressure ( MAP ) Mean pulmonary artery pressure ( MPAP ) Cardiac Index ( CI ) Systemic vascular resistance ( SVR ) Pulmonary vascular resistance ( PVR ) Right ventricular stroke work index ( RVSWI ) LVAD Flow LVAD Pulsatility Index ( PI ) These data collect five different time period first eight hour surgery . 1 . Time zero . Data collect surgery upon arrival CTICU receiving iNO . 2 . After two hour data collect . iPGI2 combine current iNO . 3 . After two hour combine iNO iPGI2 , data collect . iNO stop . 4 . Data collect two hour solo iPGI2 therapy . iNO restart . 5 . After two hour combine iNO iPGI2 , data collect . The study end data collection time .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>Tezosentan</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<criteria>adult cardiac surgical patient schedule undergo either heart transplantation leave ventricular assist device ( LVAD ) placement Patients prior document allergic reaction intolerance either nitric oxide prostacyclin exclude . Patients undergoing heart transplantation LVAD placement exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>heart failure</keyword>
	<keyword>hypertension , pulmonary</keyword>
	<keyword>heart failure , right-sided</keyword>
	<keyword>heart-assist device</keyword>
	<keyword>Heart Transplantation</keyword>
</DOC>